Australia markets closed

Genetic Technologies Limited (GTG.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0630-0.0050 (-7.35%)
At close: 04:10PM AEST
Full screen
Previous close0.0680
Open0.0690
Bid0.0620 x 0
Ask0.0660 x 0
Day's range0.0620 - 0.0690
52-week range0.0620 - 0.1850
Volume272,233
Avg. volume134,941
Market cap6.567M
Beta (5Y monthly)0.51
PE ratio (TTM)N/A
EPS (TTM)-0.0100
Earnings date28 Aug 2024 - 01 Sept 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    GeneType to Enter Canadian and New Zealand Markets

    Genomics-based testing brand expands international presence as pilot influencer campaign fuels salesCHARLOTTE, N.C., July 09, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in genomics-based tests in health, wellness and serious disease and the parent company of geneType™, today announced the introduction of geneType’s suite of genetic risk assessment tests to Canada and New Zealand. Dovetailing geneType’s recent expansion to the

  • GlobeNewswire

    GeneType Identifies 79.5% of People Tested are at Risk of Serious Disease

    Results from commercial sales of predictive testing across the US and Australia establish clear advantages of geneType Risk Assessment Tests for a more preventive approach in disease managementCHARLOTTE, N.C., June 25, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in genomics-based tests in health, wellness and serious disease, is pleased to share the power of the geneType test in identifying risk and improving the health of pop

  • GlobeNewswire

    Join Genetic Technologies’ Exclusive Live Investor Webinar and Q&A Session on June 27

    CHARLOTTE, N.C. and MELBOURNE, Australia, June 21, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (NASDAQ:GENE, ASX:GTG, “Company”, “GTG”, or “Genetic Technologies”), a global leader in guideline-driven genomics-based tests in health, wellness and serious diseases, is pleased to invite investors to a webinar on June 27, 2024, at 4:15 p.m. ET. The exclusive event, hosted by RedChip Companies, will feature Simon Morriss, CEO of Genetic Technologies, who will share insight into the Company’s